Supreme Court tosses $1.25 million verdict for man who says Roundup caused his cancer
Supreme Court Tosses $1.25M Verdict in Roundup Cancer Case
Supreme Court tosses 1 25 million – The U.S. Supreme Court recently overturned a $1.25 million jury award given to a Missouri man who claimed that Roundup caused his cancer. In a 7-2 decision, the justices ruled in favor of Monsanto, the herbicide’s manufacturer, which argued that the federal government does not require cancer warnings on Roundup labels. Justice Brett Kavanaugh wrote the majority opinion, while Justices Ketanji Brown Jackson and Neil Gorsuch dissented, questioning the court’s legal interpretation. This ruling has significant implications for similar lawsuits and the balance of regulatory authority between federal and state laws.
John Durnell’s Case and the Legal Debate
John Durnell, a St. Louis resident known as the “spray man” for his frequent use of Roundup in local parks, became the center of this high-profile case. After developing non-Hodgkin lymphoma, he sued Monsanto, asserting that his prolonged exposure to the herbicide led to his illness. The jury initially agreed, awarding him $1.25 million in damages. However, the Supreme Court’s decision to toss the verdict has cast doubt on the validity of such claims, potentially affecting thousands of other Roundup-related lawsuits.
Durnell’s claim rested on the argument that Monsanto failed to include cancer warnings on its product, despite the EPA’s stance that glyphosate, the active ingredient in Roundup, is not carcinogenic. The court’s ruling supports Monsanto’s assertion that federal law, specifically the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), preempts state-level requirements. This means that companies can set their own labeling standards under federal guidelines, which may limit the ability of plaintiffs to pursue state-based claims against pesticide manufacturers.
“The Supreme Court’s decision to toss the $1.25 million verdict signals a shift in how cancer risks are assessed in the legal system,” said environmental advocacy groups. “It raises questions about whether state laws can hold companies accountable for products deemed safe at the federal level.”
Political and Industry Impact
The ruling has drawn attention from political figures and industry stakeholders alike. President Donald Trump’s “Make America Healthy Again” initiative has framed the decision as a victory for reducing regulatory burdens on businesses. During the case’s arguments in early April, supporters of stricter pesticide regulations gathered in record numbers at the Supreme Court, highlighting the public’s growing concern over chemical safety. However, the Trump administration’s backing of Monsanto suggests a preference for federal oversight over state-level litigation.
Robert F. Kennedy Jr., who previously led efforts to challenge glyphosate’s safety, was part of the team representing DeWayne “Lee” Johnson, a San Francisco school groundskeeper diagnosed with terminal non-Hodgkin lymphoma in 2014. Johnson’s case was a major catalyst for Roundup-related litigation, especially after the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” in 2015. Despite his earlier advocacy for stronger regulations, Kennedy’s role in this case has been overshadowed by the Supreme Court’s decision to toss the $1.25 million verdict.
The court’s ruling also reflects a broader trend of federal preemption in environmental and health litigation. Monsanto’s legal strategy, centered on FIFRA, argues that state laws cannot override federal standards, creating a uniform system for pesticide approval. This approach has been supported by business groups like the Chamber of Commerce, which worry that inconsistent state regulations could lead to increased litigation across industries, including medical devices, cosmetics, and pet food. The Supreme Court’s decision to toss the $1.25 million verdict aligns with this vision of streamlined regulatory enforcement.
